Cultured fibroblasts in Huntington's disease. I. Effects of L-glutamic acid

Archives of Neurology
|January 1, 1983
PubMed

Insights

Huntington's disease (HD) fibroblasts show increased sensitivity to L-glutamic acid. This suggests potential abnormalities in the glutamine cycle beyond the central nervous system in HD patients.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Huntington's disease (HD) is linked to central nervous system (CNS) defects potentially involving the glutamine cycle.
  • Conflicting evidence exists regarding whether other cell types exhibit similar abnormalities.

Purpose of the Study:

  • To investigate the role of the glutamine cycle in non-CNS cells of Huntington's disease patients.
  • To assess the impact of L-glutamic acid on fibroblast function in HD.

Main Methods:

  • Utilized 30 HD, 20 at-risk, and 20 normal human cell lines.
  • Assessed cell viability, plating efficiency, and growth.
  • Measured glutamine rescue and incorporation of tritiated thymidine and leucine with varying L-glutamic acid concentrations.

Main Results:

  • Decreased cell viability, plating efficiency, and growth were observed with increasing L-glutamic acid concentrations in HD cells.
  • Glutamine rescue was significantly less effective in HD cells compared to normal cells.
  • HD fibroblasts demonstrated slightly higher sensitivity to L-glutamic acid than normal cells.

Conclusions:

  • Fibroblasts from Huntington's disease patients exhibit altered responses to L-glutamic acid, suggesting potential glutamine cycle dysfunction outside the CNS.
  • These findings indicate that HD-related cellular abnormalities may extend to peripheral cell types.

Related Concept Videos